The findings align with the PROLONG registry and bolster evidence for limiting the duration of antithrombotic therapy.

The largest ethnic minority in the US faces earlier disease onset along with access issues and misconceptions about ...

The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ...

Lead author Amar Rai, MBBS (University of Pennsylvania, Philadelphia, and Imperial College London, England), said that as a clinician working with patients who have high bleeding risks in general, he ...

HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are ...

TCTMD's Todd Neale spoke with Warraich about the ADVOCATE program, which has its sights set on heart failure first.

The latest UDMI aims to align classifications with pathology and clinical practice, bringing numerous changes to the 2018 ...

The US Food and Drug Administration has approved the Selution SLR sirolimus-eluting balloon for the treatment of coronary ...

MACE risk appeared to be higher in cases for which there was disagreement, perhaps identifying the need for a closer look.

The data “give you pause” when considering closure, especially for women who can tolerate DOACs, Christine Albert says.

CRF ® is committed to igniting the next wave of innovation in research and education that will help docto ...

Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.